CLERE AG DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER. FIRST BERLIN Equity Research. Delisting & PRICE TARGET C L

Similar documents
18 November 2016 Energiekontor AG. FIRST BERLIN Equity Research

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research

Intershop Communications AG

14 September 2017 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 216.5% ISIN: NL

18 October 2016 aventron AG. FIRST BERLIN Equity Research

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research

24 May 2016 Energiekontor AG. FIRST BERLIN Equity Research

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research

6 September 2016 aventron AG. FIRST BERLIN Equity Research

5 September 2016 OTI Greentech AG. FIRST BERLIN Equity Research

18 January 2018 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 45.9% ISIN: NL

14 August 2017 PNE WIND AG. FIRST BERLIN Equity Research

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS

26 April 2017 aventron AG. FIRST BERLIN Equity Research

HAEMATO AG MARKET SHARE WIN IN PARALLEL IMPORT BUSINESS. FIRST BERLIN Equity Research H1/18 PRICE TARGET H A

Advanced Vision Technology

18 May 2018 Pharming Group NV. FIRST BERLIN Equity Research

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research

19 December 2016 NOXXON Pharma NV. FIRST BERLIN Equity Research. Cooperation

Aroundtown SA LATEST RUN RATES CONFIRM GROWTH PHASE. FIRST BERLIN Equity Research. Operational PRICE TARGET Ar ou

ad pepper media International N.V.

26 October 2017 Energiekontor AG. FIRST BERLIN Equity Research. Update. Bloomberg: EKT GR Return Potential 67.2% ISIN: DE

24 September 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research

6 June 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 44.2% ISIN: DE000A1EWVY8

8 May 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 36.3% ISIN: DE000A1EWVY8

7 March 2017 Sirona Biochem Corp. FIRST BERLIN Equity Research FY16. PRICE TARGET C$0.95 Secondary: Quotation Board Frankfurt.

11 January 2018 Deutsche Rohstoff AG. FIRST BERLIN Equity Research. Update. Bloomberg: DR0 GR Return Potential 40.2% ISIN: DE000A0XYG76

Schloss Wachenheim AG

14 November 2018 M1 Kliniken AG. FIRST BERLIN Equity Research. H1/18 figures &

Aroundtown Property Holdings Plc.

27 February 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research. Smart Meter Gateway BENEFITING FROM DIGITISATION OF HEALTH AND ENERGY MARKETS

18 May 2018 Energiekontor AG. FIRST BERLIN Equity Research

Almonty Industries inc.

9 November 2018 Valneva SE. FIRST BERLIN Equity Research

16 April 2018 Epigenomics AG. FIRST BERLIN Equity Research. Update. Bloomberg: ECX Return Potential 96.9% ISIN: DE000A11QW50

Deutsche Biotech Innovativ AG

European Lithium Limited

28 March 2019 PAION AG. FIRST BERLIN Equity Research

MPH Mittelstaendische Pharma Holding AG M P

4 July 2017 PAION AG. FIRST BERLIN Equity Research. Update. Bloomberg: PA8 GR Return Potential 44.5% ISIN: DE000A0B65S3

Almonty Industries inc.

12 December 2018 Pharming Group NV. FIRST BERLIN Equity Research. acute HAE therapies HEAD-TO-HEAD STUDY GIVES PHARMING NEW WEAPON AGAINST FIRAZYR

23 May 2018 HAEMATO AG. FIRST BERLIN Equity Research RECORD SALES IN H2; FIRST MEDICAL PRODUCTS SHIPPED

Almonty Industries Inc.

Schloss Wachenheim AG

7C Solarparken GUIDANCE FOR 2016 INCREASED. FIRST BERLIN Equity Research. Preliminary 2014 PRICE TARGET 2.10

5 October 2016 Deutsche Rohstoff AG. FIRST BERLIN Equity Research

5 November C Solarparken AG. FIRST BERLIN Equity Research

22 September 2017 MOLOGEN AG. FIRST BERLIN Equity Research. Update. Bloomberg: MGN GR Return Potential 447.3% ISIN: DE

25 April 2014 OpenLimit Holding AG. FIRST BERLIN Equity Research

Rock Tech Lithium Inc.

4 October 2017 HAEMATO AG. FIRST BERLIN Equity Research H1/17 OPERATIONS RUNNING WELL DESPITE SLUGGISH FIRST HALF

German Startups Group Berlin GmbH & Co. KGaA

Borussia Dortmund GmbH & Co. KGaA

Geratherm Medical AG Strong demand in Q3

Golden Daw n Minerals Inc.

Solid preliminary FY 2014 results released. Net asset value increased by 3.5% in H 2014 with difficult trading environment

GRAND CITY Properties S.A.

BUY (previous: BUY) (previous: 77.50)

Price Target: EUR 4.15 (3.80)

BDI BioEnergy Internat Buy

NOT RATED. (previously Buy) (previously 1.73) adj. net (mln ) DPS ( ) adj. EPS ( )

FIRST BERLIN Equity Research

Indygotech Minerals S.A.

ISRA VISION Neutral

PA Power Automation AG

Advanced Vision Techn Buy

Deutsche Biotech Innovativ AG

Electronics Line 3000 Ltd.

Borussia Dortmund GmbH & Co. KGaA

Evaluation result Fair value DPS. adj. net. adj. EPS ( )

PA Power Automation AG

MATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation

Buy PT EUR24,00, upside 23%

Research Note. Fair Value REIT-AG

Financials/Prime Standard

HOLD 51,85. (previous: Hold) (previous: 51,65)

EQUINET INVESTIGATOR

Public Share Purchase Offer. Rocket Internet SE. Charlottenstraße 4, Berlin, Germany. to its shareholders

Key ratios Sales adj. net

TEMPORARILY NO VALUATION. (previous: not rated)

HOLD (previous: BUY) (previous: 68.00)

Sandpiper Digital Payments AG

Tel.: +49 (0) Tel.: +49 (0)

Klaus Kränzle, Please inform yourself of important disclosures and disclaimers in the appendix

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.

GOING EAST & ONE YEAR AFTER

Quiet quarter, attractive valuation

Strong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG

HOLD (previous: Hold) (previous: 51.85)

adesso AG MAY 31, 2012

Evaluation result Fair value BUY (prev.: BUY) (prev.: 21.52)

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview

Reduced EPS but smart acquisition

PrimeCity Investment Plc

BUY (previous: BUY) (previous: 3.70)

Transcription:

CLERE AG RATING Germany / Cleantech Delisting & Primary exchange: XETRA PRICE TARGET 16.33 Bloomberg: CAG GR takeover bid Return Potential 1.8% ISIN: DE0005215107 Risk Rating Medium DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER Dr. Karsten von Blumenthal, Tel. +49 (0)30-80 93 96 85 1 C L ADD Clere AG has decided to delist the share from the Frankfurt Stock Exchange, as the benefits of being listed no longer justify the expense. Clere has concluded a delisting agreement with its main shareholder, Elector GmbH. As a result, Elector is obliged to offer Clere shareholders a cash payment equivalent to a minimum of the weighted average of the share price of the last six months preceeding the publication of the decision of Elector to submit an offer to acquire all the shares. This price amounts to 16.33 per share. We believe that shareholders who do not want to end up with an illiquid share will have to accept the offer. We lower our price target to 16.33 (previously: 25.20) and downgrade the stock from Buy to Add. Delisting planned On 3 May, with the approval of the Supervisory Board, the Management Board of Clere decided to apply for the revocation of the listing of the company's shares for trading on the Regulated Market of the Frankfurt Stock Exchange (delisting). According to management, the benefits of being listed no longer justify the expense. We believe that for a company with 9 employees, minimum revenues, and a strong cash position sufficient to finance the planned acquisition of green power infrastructure assets, the benefits of being listed are indeed limited and do not justify the associated expense. Main shareholder Elector GmbH makes voluntary offer for remaining Clere shares Elector, which on 3 May owned 33.2% of the Clere shares, has offered to purchase all shares from Clere shareholders at 16.33 per share. According to 4 and 5 WpÜG-AngebV, this price corresponds to the minimum legal price for a Clere AG share during the last six months prior to the publication of the decision of Elector to submit the offer. The acceptance period runs from 24 May to 22 June. The German regulatory body, Bundesamt für Finanzdienstleistungsaufsicht (Federal Financial Supervisory Authority) scrutinised the offering document and approved its publication on 24 May. German law is the only applicable law for Elector s offer. (p.t.o.) COMPANY PROFILE Clere AG is active in the market for renewable energy and environmental technology. The company invests in and operates renewable energy production assets. Furthermore, Clere plans to finance medium-sized companies. Clere is headquartered in Berlin, Germany. MARKET DATA As of 31 May 2017 Closing Price 16.05 Shares outstanding 5.89m Market Capitalisation 94.49m 52-week Range 14.80 / 27.98 Avg. Volume (12 Months) 9,451 Multiples 2014/15 2015/16 2016 P/E n.a. 3.3 23.9 EV/Sales n.m. n.m. n.m. EV/EBIT n.a. n.a. n.a. Div. Yield 124.6% 0.0% 0.0% STOCK OVERVIEW 30 28 26 24 22 20 18 16 14 May 16 Jul 16 Sep 16 Nov 16 Jan 17 Mar 17 May 17 Clere AG OEKODAX Index 45 40 35 30 25 20 FINANCIAL HISTORY & PROJECTIONS 2012 2012/13 2013/14 2014/15 2015/16 2016 Revenue ( m) 24.71 59.91 70.52 85.44 0.00 0.60 Y-o-y growth -62.8% 142.5% 17.7% 21.2% n.a. n.a. EBIT ( m) -14.70-12.63-4.73-12.07-6.74-3.02 EBIT margin -59.5% -21.1% -6.7% -14.1% n.a. n.a. Net income ( m) 250.70 13.48 5.86-12.74 32.75 3.95 EPS (diluted) ( ) 42.57 2.29 1.00-2.16 5.56 0.67 DPS ( ) 20.00 0.00 15.00 20.00 0.00 0.00 FCF ( m) -6.40 168.90 5.09 0.40 98.37-6.82 Net gearing -90.2% -84.2% -80.2% -83.2% -149.2% n.a. Liquid assets ( m) 401.20 283.30 194.80 199.24 172.55 104.11 COMPANY DATA As of 30 Mar 2017 Liquid Assets 105.20m Current Assets 153.08m Intangible Assets 0.23m Total Assets 161.78m Current Liabilities 11.05m Shareholders Equity 148.15m SHAREHOLDERS Elector GmbH 35.4% Free Float 64.6% RISKS The main risks to our price target are investment risks, legal and regulatory risks. Analyst: Dr. Karsten von Blumenthal, Tel. +49 (0)30-80 93 96 85

Delisting makes stock illiquid After the delisting takes effect, Clere AG shares will no longer be authorised for trading and will no longer be traded on a domestic regulated market or a comparable foreign market. Although this does not rule out all kinds of trading, trading volumes look set to be low and transaction costs high in the absence of trading possibilities on the regulated market and due to an expected lower free float. The Executive Board of the Frankfurt Stock Exchange will make a decision in due course regarding the application for the revocation of the listing of the Clere share. We expect that the delisting will take effect, in accordance with the provisions of the Exchange Regulations of the Frankfurt Stock Exchange, three trading days after the publication of the delisting. This will take place following a positive decision of the Frankfurt Stock Exchange. Cash or keeping a soon to be illiquid stock Shareholders are confronted with the alternatives of keeping a soon to be illiquid stock or accepting the offer price ( 16.33) which is below our previous fair value estimate of 25.20. But as Elector s offer is according to our understanding in compliance with German law we do not see any chance that shareholders will receive a higher price. Downgrade to Add at lower price target As we do not believe that the price shareholders will receive for their Clere shares will exceed the offering price of 16.33 in the foreseeable future, we lower our price target to 16.33 (previously: 25.20). We downgrade the stock from BUY to ADD, given the reduced upside potential. Page 2/5

RECOMMENDATION & PRICE TARGET HISTORY Report No.: Initial Report Date of publication Previous day closing price Recommendation Price target 3 March 2006 56.50 Buy 92.00 2...46 47 17 October 2016 18.52 Buy 25.40 48 14 November 2016 18.47 Buy 24.80 49 29 April 2017 15.36 Buy 25.20 50 Today 16.05 Add 16.33 Authored by: Dr. Karsten von Blumenthal, Analyst Company responsible for preparation: First Berlin GmbH Mohrenstraße 34 10117 Berlin Tel. +49 (0)30-80 93 96 85 Fax +49 (0)30-80 93 96 87 info@firstberlin.com www.firstberlin.com Person responsible for forwarding or distributing this financial analysis: Martin Bailey Copyright 2017 First Berlin GmbH No part of this financial analysis may be copied, photocopied, duplicated or distributed in any form or media whatsoever without prior written permission from First Berlin GmbH. First Berlin GmbH shall be identified as the source in the case of quotations. Further information is available on request. INFORMATION PURSUANT TO SECTION 34B OF THE GERMAN SECURITIES TRADING ACT [WPHG], TO REGULATION (EU) NO 596/2014 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL OF APRIL 16, 2014, ON MARKET ABUSE (MARKET ABUSE REGULATION) AND TO THE GERMAN ORDINANCE ON THE ANALYSIS OF FINANCIAL INSTRUMENTS [FINANV] First Berlin GmbH (hereinafter referred to as: First Berlin ) prepares financial analyses while taking the relevant regulatory provisions, in particular the German Securities Trading Act [WpHG], Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse (market abuse regulation) and the German Ordinance on the Analysis of Financial Instruments [FinAnV] into consideration. In the following First Berlin provides investors with information about the statutory provisions that are to be observed in the preparation of financial analyses. CONFLICTS OF INTEREST In accordance with Section 34b Paragraph 1 of the German Securities Trading Act [WpHG] and Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse (market abuse regulation) financial analyses may only be passed on or publicly distributed if circumstances or relations which may cause conflicts of interest among the authors, the legal entities responsible for such preparation or companies associated with them are disclosed along with the financial analysis. First Berlin offers a range of services that go beyond the preparation of financial analyses. Although First Berlin strives to avoid conflicts of interest wherever possible, First Berlin may maintain the following relations with the analysed company, which in particular may constitute a potential conflict of interest (further information and data may be provided on request): The author, First Berlin, or a company associated with First Berlin holds an interest of more than five percent in the share capital of the analysed company; The author, First Berlin, or a company associated with First Berlin provided investment banking or consulting services for the analysed company within the past twelve months for which remuneration was or was to be paid; The author, First Berlin, or a company associated with First Berlin reached an agreement with the analysed company for preparation of a financial analysis for which remuneration is owed; The author, First Berlin, or a company associated with First Berlin has other significant financial interests in the analysed company; In order to avoid and, if necessary, manage possible conflicts of interest both the author of the financial analysis and First Berlin shall be obliged to neither hold nor in any way trade the securities of the company analyzed. The remuneration of the author of the financial analysis stands in no direct or indirect connection with the recommendations or opinions represented in the financial analysis. Furthermore, the remuneration of the author of the financial analysis is neither coupled directly to financial transactions nor to stock exchange trading volume or asset management fees. If despite these measures one or more of the aforementioned conflicts of interest cannot be avoided on the part of the author or First Berlin, then reference shall be made to such conflict of interest. PRICE TARGET DATES Unless otherwise indicated, current prices refer to the closing prices of the previous trading day. AGREEMENT WITH THE ANALYSED COMPANY AND MAINTENANCE OF OBJECTIVITY The present financial analysis is based on the author s own knowledge and research. The author prepared this study without any direct or indirect influence exerted on the part of the analysed company. Parts of the financial analysis were possibly provided to the analysed company prior to publication in order to avoid inaccuracies in the representation of facts. However, no substantial changes were made at the request of the analysed company following any such provision. Page 3/5

ASSET VALUATION SYSTEM First Berlin s system for asset valuation is divided into an asset recommendation and a risk assessment. ASSET RECOMMENDATION The recommendations determined in accordance with the share price trend anticipated by First Berlin in the respectively indicated investment period are as follows: STRONG BUY: An expected favourable price trend of more than 50% combined with sizeable confidence in the quality and forecast security of management. BUY: An expected favourable price trend of more than 25% percent. ADD: An expected favourable price trend of between 0% and 25%. REDUCE: An expected negative price trend of between 0% and -15%. SELL: An expected negative price trend of more than -15%. RISK ASSESSMENT The First Berlin categories for risk assessment are low, average, high and speculative. They are determined by ten factors: Corporate governance, quality of earnings, management strength, balance sheet and financial risk, competitive position, standard of financial disclosure, regulatory and political uncertainty, strength of brandname, market capitalisation and free float. These risk factors are incorporated into the First Berlin valuation models and are thus included in the target prices. First Berlin customers may request the models. INVESTMENT HORIZON Unless otherwise stated in the financial analysis, the ratings refer to an investment period of twelve months. UPDATES At the time of publication of this financial analysis it is not certain whether, when and on what occasion an update will be provided. In general First Berlin strives to review the financial analysis for its topicality and, if required, to update it in a very timely manner in connection with the reporting obligations of the analysed company or on the occasion of ad hoc notifications. SUBJECT TO CHANGE The opinions contained in the financial analysis reflect the assessment of the author on the day of publication of the financial analysis. The author of the financial analysis reserves the right to change such opinion without prior notification. Legally required information regarding key sources of information in the preparation of this research report valuation methods and principles sensitivity of valuation parameters can be accessed through the following internet link: http://firstberlin.com/disclaimer-english-link/ SUPERVISORY AUTHORITY: Bundesanstalt für Finanzdienstleistungsaufsicht (German Federal Financial Supervisory Authority) [BaFin], Graurheindorferstraße 108, 53117 Bonn and Lurgiallee 12, 60439 Frankfurt EXCLUSION OF LIABILITY (DISCLAIMER) RELIABILITY OF INFORMATION AND SOURCES OF INFORMATION The information contained in this study is based on sources considered by the author to be reliable. Comprehensive verification of the accuracy and completeness of information and the reliability of sources of information has neither been carried out by the author nor by First Berlin. As a result no warranty of any kind whatsoever shall be assumed for the accuracy and completeness of information and the reliability of sources of information, and neither the author nor First Berlin, nor the person responsible for passing on or distributing the financial analysis shall be liable for any direct or indirect damage incurred through reliance on the accuracy and completeness of information and the reliability of sources of information. RELIABILITY OF ESTIMATES AND FORECASTS The author of the financial analysis made estimates and forecasts to the best of the author s knowledge. These estimates and forecasts reflect the author s personal opinion and judgement. The premises for estimates and forecasts as well as the author s perspective on such premises are subject to constant change. Expectations with regard to the future performance of a financial instrument are the result of a measurement at a single point in time and may change at any time. The result of a financial analysis always describes only one possible future development the one that is most probable from the perspective of the author of a number of possible future developments. Any and all market values or target prices indicated for the company analysed in this financial analysis may not be achieved due to various risk factors, including but not limited to market volatility, sector volatility, the actions of the analysed company, economic climate, failure to achieve earnings and/or sales forecasts, unavailability of complete and precise information and/or a subsequently occurring event which affects the underlying assumptions of the author and/or other sources on which the author relies in this document. Past performance is not an indicator of future results; past values cannot be carried over into the future. Consequently, no warranty of any kind whatsoever shall be assumed for the accuracy of estimates and forecasts, and neither the author nor First Berlin, nor the person responsible for passing on or distributing the financial analysis shall be liable for any direct or indirect damage incurred through reliance on the correctness of estimates and forecasts. INFORMATION PURPOSES, NO RECOMMENDATION, SOLICITATION, NO OFFER FOR THE PURCHASE OF SECURITIES The present financial analysis serves information purposes. It is intended to support institutional investors in making their own investment decisions; however in no way provide the investor with investment advice. Neither the author, nor First Berlin, nor the person responsible for passing on or distributing the financial analysis shall be considered to be acting as an investment advisor or portfolio manager vis-à-vis an investor. Each investor must form his own independent opinion with regard to the suitability of an investment in view of his own investment objectives, experience, tax situation, financial position and other circumstances. The financial analysis does not represent a recommendation or solicitation and is not an offer for the purchase of the security specified in this financial analysis. Consequently, neither the author nor First Berlin, nor the person responsible for passing on or distributing the financial analysis shall as a result be liable for losses incurred through direct or indirect employment or use of any kind whatsoever of information or statements arising out of this financial analysis. A decision concerning an investment in securities should take place on the basis of independent investment analyses and procedures as well as other studies including, but not limited to, information memoranda, sales or issuing prospectuses and not on the basis of this document. Page 4/5

NO ESTABLISHMENT OF CONTRACTUAL OBLIGATIONS By taking note of this financial analysis the recipient neither becomes a customer of First Berlin, nor does First Berlin incur any contractual, quasi-contractual or pre-contractual obligations and/or responsibilities toward the recipient. In particular no information contract shall be established between First Berlin and the recipient of this information. NO OBLIGATION TO UPDATE First Berlin, the author and/or the person responsible for passing on or distributing the financial analysis shall not be obliged to update the financial analysis. Investors must keep themselves informed about the current course of business and any changes in the current course of business of the analysed company. DUPLICATION Dispatch or duplication of this document is not permitted without the prior written consent of First Berlin. SEVERABILITY Should any provision of this disclaimer prove to be illegal, invalid or unenforceable under the respectively applicable law, then such provision shall be treated as if it were not an integral component of this disclaimer; in no way shall it affect the legality, validity or enforceability of the remaining provisions. APPLICABLE LAW, PLACE OF JURISDICTION The preparation of this financial analysis shall be subject to the law obtaining in the Federal Republic of Germany. The place of jurisdiction for any disputes shall be Berlin (Germany). NOTICE OF DISCLAIMER By taking note of this financial analysis the recipient confirms the binding nature of the above explanations. By using this document or relying on it in any manner whatsoever the recipient accepts the above restrictions as binding for the recipient. QUALIFIED INSTITUTIONAL INVESTORS First Berlin financial analyses are intended exclusively for qualified institutional investors. This report is not intended for distribution in the USA, Canada and/or the United Kingdom (Great Britain). Page 5/5